Back to Experiments
Mar 18, 2026Mar 14, 2026Mar 9, 2026
BPC-157 for knee recovery
ActiveBPC-157TB-500Mar 6 – May 1, 2026
Progress
18/56
days
Adherence
86%
on schedule
Doses
31/36
logged
Next Dose
2h 15m
BPC-157 PM
Experiment Timeline
Protocol Details
BPC-157250mcg
2x daily · Subcutaneous · 8 weeks
TB-5002mg
2x weekly · Subcutaneous · 8 weeks
Recent Dose Log
| Date | Time | Peptide | Dose | Site |
|---|---|---|---|---|
| Mar 23 | 08:15 AM | BPC-157 | 250mcg | Abdomen (left) |
| Mar 22 | 09:00 PM | BPC-157 | 250mcg | Abdomen (right) |
| Mar 22 | 08:30 AM | BPC-157 | 250mcg | Abdomen (left) |
| Mar 22 | 08:30 AM | TB-500 | 2mg | Deltoid (left) |
| Mar 21 | 08:45 PM | BPC-157 | 250mcg | Abdomen (right) |
| Mar 21 | 08:10 AM | BPC-157 | 250mcg | Abdomen (left) |
| Mar 20 | 09:15 PM | BPC-157 | 250mcg | Abdomen (right) |
| Mar 20 | 08:00 AM | BPC-157 | 250mcg | Abdomen (left) |
| Mar 19 | 08:50 PM | BPC-157 | 250mcg | Abdomen (right) |
| Mar 19 | 08:20 AM | BPC-157 | 250mcg | Abdomen (left) |
Side Effects
Mild injection site rednessmild
Resolved within 30 minutes, no swelling.
Slight drowsiness after PM dosemild
Lasted approximately 1 hour post-injection.
Temporary nausea after first TB-500 dosemoderate
Subsided after 2 hours. Ate beforehand on subsequent doses — no recurrence.